Paras Healthcare IPO 2026: ₹1,450 Crore Issue, Price Band, Dates and Review
Summary
- Paras Healthcare’s ₹1,450-crore IPO is scheduled to open on 21 October and close on 23 October 2026.
- The price band is ₹660–₹693 per equity share, with a minimum application of 21 shares.
- The issue includes ₹500 crore in fresh equity and ₹950 crore through an offer for sale.
- The hospital operator reported FY2026 profit of ₹43.83 crore, reversing the previous year’s loss.
- Debt repayment and future hospital expansion are central considerations for investors.
Paras Healthcare IPO: Latest update
Paras Healthcare Limited, which operates hospitals under the Paras Health brand, is preparing to enter India’s listed equity market through an initial public offering.
The company’s red herring prospectus is recorded in the Securities and Exchange Board of India’s public-issue filings dated 15 October 2026. The offer will open to public investors on 21 October and close on 23 October.
The issue is attracting attention because Paras Healthcare operates a growing hospital network in northern and eastern India and has recently returned to profitability.
However, the business also requires substantial capital to operate and expand medical facilities. Investors need to examine the price, earnings, debt profile and use of proceeds rather than judging the offering simply by the rising demand for healthcare.
As of 18 October, public subscription has not yet opened.
Paras Healthcare IPO: Key details
| Particular | Details |
|---|---|
| IPO opening | 21 October 2026 |
| IPO closing | 23 October 2026 |
| Price band | ₹660–₹693 |
| Total issue | ₹1,450 crore |
| Fresh issue | ₹500 crore |
| Offer for sale | ₹950 crore |
| Lot size | 21 shares |
| Minimum application at ₹693 | ₹14,553 |
| Listing exchanges | NSE and BSE |
| Allotment and listing | Subject to final offer timetable |
What is the minimum investment?
An application for one lot consists of 21 shares.
At the upper price band, the calculation is:
21 × ₹693 = ₹14,553.
Two lots would require ₹29,106 at that price.
Investors should confirm the permitted retail application limits and lot multiples in the final bidding interface. Completing an application does not guarantee allotment.
Fresh issue versus offer for sale
The proposed ₹1,450-crore IPO consists of two distinct components.
₹500-crore fresh issue
Paras Healthcare will issue new shares to raise up to ₹500 crore. After applicable issue expenses, the money can be used for the company’s stated business objectives.
₹950-crore offer for sale
Existing shareholders will sell shares through the offer for sale, commonly called OFS. The money from this portion goes to the selling shareholders, not to Paras Healthcare.
This difference matters because the full IPO amount does not become new capital on the company’s balance sheet.
Investors should also examine the promoters’ post-issue shareholding and any applicable lock-in arrangements.
How will IPO proceeds be used?
The company plans to use a substantial portion of fresh-issue proceeds for debt repayment.
Published issue details indicate that ₹320.90 crore is earmarked for repayment or prepayment of certain company borrowings.
Another ₹54.10 crore is intended for investment in the wholly owned subsidiary Plus Medicare Hospitals Private Limited, to facilitate debt repayment.
The remaining approximately ₹125 crore is allocated towards general corporate purposes, subject to the final offer terms and issue expenses.
Reducing debt may lower interest expenses, strengthen the financial position and provide additional flexibility for future investments.
Nevertheless, debt repayment alone does not guarantee sustained profitability. The business must continue earning adequate operating cash flows.
About Paras Healthcare Limited
Paras Healthcare operates a specialist-led hospital network offering tertiary and quaternary medical care.
Its services encompass multiple medical and surgical specialties, including complex hospital treatments that require trained healthcare professionals and advanced equipment.
The network has eight hospitals across locations including Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar.
Reported aggregate capacity is approximately 2,211 beds.
A strategy focused on regional healthcare markets offers potential opportunities because patients increasingly seek specialist treatment closer to home rather than travelling to major metropolitan cities.
However, smaller markets can differ substantially in patient income, insurance penetration, doctor availability and treatment demand.
Proposed hospital expansion
The company has outlined future projects, including a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana.
Successful completion could increase its network capacity substantially.
These projects remain plans, not operational capacity already available to patients. Hospital development can face delays, construction costs and regulatory requirements.
Paras Healthcare financial performance
The business reported improving revenue and profitability for FY2026.
| Indicator | FY2025 | FY2026 |
|---|---|---|
| Total income | ₹1,314.21 crore | ₹1,628.78 crore |
| EBITDA | ₹156.46 crore | ₹335.58 crore |
| Profit after tax | −₹57.98 crore | ₹43.83 crore |
Total income increased approximately 24% year-on-year.
The company also reported a quarterly profit after tax of approximately ₹49.68 crore for the three months ended 30 June 2026.
While the turnaround is encouraging, a profitable year following previous losses is not the same as an established record of consistent profitability.
Investors should compare several years of cash flows and earnings, not only the most recent quarter.
How important is debt?
Hospital businesses require substantial investment in land, buildings, medical equipment, technology and staff.
Borrowings can accelerate expansion but also create recurring financing costs.
Published issue reporting puts Paras Healthcare’s broader reported borrowings at approximately ₹1,429.49 crore as of June 2026. Investors should reconcile this figure with the precise borrowing definitions, lease-related liabilities and consolidated financial schedules in the RHP before making valuation comparisons.
The proposed debt repayment could reduce part of this burden, but the company may need further capital for expansion.
Questions worth examining include whether hospital cash generation is sufficient to fund maintenance, whether new facilities are initially loss-making and how quickly occupancy reaches sustainable levels.
More Stories
ixigo Q2 Results: Profit Reaches ₹63.42 Crore, Revenue Rises 13% as Hotels Business Expands
FPI Outflows October 2026: Foreign Investors Withdraw ₹52,100 Crore From Indian Stocks
Paras Healthcare IPO 2026: ₹1,450 Crore Issue, Price Band, Dates and Review
57th GST Council Meeting 2026: Major Reforms Proposed for Taxpayers and Businesses
Major risks in the Paras Healthcare IPO
Operating and expansion costs
Hospitals typically have significant fixed costs. A newly opened facility may need years to develop referral networks and achieve stable patient volumes.
Competition
Paras Healthcare competes with national hospital chains, regional providers and specialist institutions.
Competition affects pricing, recruitment and patient retention.
Dependence on doctors and nurses
A hospital’s reputation and operational capacity depend heavily on qualified healthcare professionals.
Staff turnover and recruitment costs can influence profitability.
Regulation and medical liability
Hospitals must comply with medical, safety and licensing requirements. Adverse clinical events and legal claims can also create financial and reputational risks.
IPO valuation
At the upper price band, published estimates indicate a post-issue valuation of around ₹7,500 crore.
Investors should evaluate earnings, debt, operating cash flow and hospital-network prospects alongside comparable listed companies.
An expanding healthcare business is not automatically an attractive investment at every price.
How can investors apply?
Eligible applicants can submit bids through supported brokers or banks using the prescribed ASBA or UPI mandate process.
Investors should verify the company name, lot size, price band and application dates before approving a mandate.
The blocked amount is handled according to the applicable bidding and allotment process.
Applicants must never disclose their UPI PIN to anyone. The PIN should be entered only in the authorised payment interface.
What should investors monitor next?
The next important developments include anchor-investor participation, daily subscription figures, the basis of allotment and final listing arrangements.
Subscription levels alone should not determine an investment decision.
Strong demand may reflect several market factors, while the company’s long-term value depends on its ability to deliver sustainable earnings and cash flows.
Conclusion
Paras Healthcare’s ₹1,450-crore IPO offers exposure to an established hospital operator with expansion ambitions and recently improved profitability.
The planned use of funds for debt reduction is an important feature of the issue.
However, valuation, borrowings, capital expenditure and the sustainability of earnings remain central risks.
Investors should read the RHP and assess the business fundamentals before placing a bid.
Sources: Paras Healthcare official IPO documents, SEBI public-issues register.
Disclaimer: This article was prepared with AI assistance for general educational information. It is not investment advice. EduTaxTuber is not liable for losses to the extent permitted by applicable law. Verify all issue details against the latest official documents.
Disclaimer: EduTaxTuber provides content for general educational and informational purposes only. While we make reasonable efforts to keep the information accurate and updated, laws, regulations, market conditions, software features, and other information may change. Some content may be created or assisted by AI tools and may contain errors or omissions. Readers should verify important information with official sources or qualified professionals before making any tax, legal, financial, investment, business, or other decisions. EduTaxTuber does not guarantee the completeness or accuracy of the information and does not provide professional advice.
